Nitromed News
Most Popular Nitromed Story
NeurAxon builds a house on pain
In his own words, Lawrence Bloch believes in putting his money where his mouth is. For the last few weeks, his mouth has devoted much of its work to touting the future of NeurAxon, an early-stage... Read more...
Latest Headlines
- May 7, 2009
- January 30, 2009
- November 19, 2008
- April 2, 2008
- September 6, 2007
- January 23, 2007
- January 22, 2007
- October 10, 2006
- March 30, 2006
- March 21, 2006
- July 7, 2005
- July 7, 2005
- June 16, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
